Combination Therapy for Overactive Bladder: Should We Define Refractoriness?
Eur Urol
.
2019 Dec;76(6):780-781.
doi: 10.1016/j.eururo.2019.09.003.
Epub 2019 Sep 18.
Authors
Bárbara Padilla-Fernández
1
,
David M Castro-Díaz
2
Affiliations
1
Department of Urology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain. Electronic address: padillaf83@hotmail.com.
2
Department of Urology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
PMID:
31540792
DOI:
10.1016/j.eururo.2019.09.003
No abstract available
Publication types
Editorial
Comment
MeSH terms
Combined Modality Therapy
Drug Therapy, Combination
Humans
Muscarinic Antagonists
Urinary Bladder, Overactive*
Substances
Muscarinic Antagonists